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and Anna Wedell2,7,8,17
S-adenosylmethionine (SAM) is the predominantmethyl group donor and has a large spectrumof target substrates. As such, it is essential
for nearly all biological methylation reactions. SAM is synthesized by methionine adenosyltransferase frommethionine and ATP in the
cytoplasm and subsequently distributed throughout the different cellular compartments, includingmitochondria, wheremethylation is
mostly required for nucleic-acid modifications and respiratory-chain function. We report a syndrome in three families affected by
reduced intra-mitochondrial methylation caused by recessive mutations in the gene encoding the only known mitochondrial SAM
transporter, SLC25A26. Clinical findings ranged from neonatal mortality resulting from respiratory insufficiency and hydrops to child-
hood acute episodes of cardiopulmonary failure and slowly progressive muscle weakness. We show that SLC25A26 mutations cause
various mitochondrial defects, including those affecting RNA stability, protein modification, mitochondrial translation, and the biosyn-
thesis of CoQ10 and lipoic acid.Altered S-adenosylmethionine (SAM) concentrations in
the cytoplasm have been suggested to be involved in the
pathophysiology of disease and in the natural aging pro-
cess.1,2 Highly specialized methyltransferases, encoding
approximately 1%–2% of eukaryotic genomes,3 use SAM
as a methyl group donor to methylate their targets. The
human mitochondrial SAM carrier (SAMC), encoded by
SLC25A26 (MIM: 611037), is expressed in all human
tissues examined and is believed to be the only route of
SAM entry intomitochondria.4 However, regulatorymech-
anisms of intra-mitochondrial SAM (mtSAM) concentra-
tions or other pathways modulating mtSAM levels are
unknown, and so far the pathophysiological consequences
of reduced mitochondrial SAM import are unclear.
We identified three families with different ethnic origins
and a complex biochemical phenotype caused by muta-
tions in SLC25A26. Individual 1 (P1, individual II:2 from
family 1 in Figure 1A) was born to consanguineous par-
ents from Iraq and presented at 4 weeks with acute circu-
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episode of pulmonary hypertension, which also normal-
ized. At 6 years 3 months, the boy had increasing muscle
weakness, fatigue, recurrent abdominal pain, lack of appe-
tite, and slightly delayed development. Investigation of
mitochondrial function from a muscle biopsy revealed
reduced activities of complexes I and IV and a reduced
ATP production rate, in particular when pyruvate was
used as a substrate (Figures S1A and S1B). Histology
showed the presence of COX-negative muscle fibers
(Figure S1C). Additionally, Blue-native PAGE (BN-PAGE)
revealed reduced levels of assembled complexes I and IV
(Figure S1D). Individual 2 (P2, II:1 from family 2 in
Figure 1A), born to Japanese parents, developed severe lac-
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Figure 1. Identification of Mutations in SLC25A26
(A) Pedigrees of individuals P1–P3 indicate the inheritance patterns in the individuals’ families. P1 was born to consanguineous parents
from Iraq after a normal pregnancy and neonatal period. P2 was born full term to unrelated parents from Japan with an Apgar score of
9-10. P3 was born to consanguineous parents of Moroccan descent. Symbols and colors are defined as follows: square, male; circle,
female; triangle, miscarriage with unknown gender; white, unaffected; dot, unaffected carrier; black, affected. WT indicates wild-type.
(B) Diagram representing the relative positions of SLC25A26 mutations (NM_173471.3) and SLC25A26 alterations (GenBank:
NP_775742.4). Amino acid alignments of eight species show the regions of each mutation.
(C) SLC25A26mutation c.33þ1G>A causes an RNA-splicing defect: the top band in lanes 2–5 indicates the amplification of the principal
isoform (PI; Ensembl: ENST00000354883), and the lower band in lanes 2–5 indicates the amplification of the shorter isoform (SI; En-
sembl: ENST00000336733). As a result of the mutation, PCR products from the individual, treated both with and without puromycin,
were observed to be shorter in length (top band: PI around 572 bp; lower band: SI around 415 bp) than those of the control fibroblasts
and lymphocytes (top band: PI 617 bp; lower band: SI 450 bp). No difference was observed between the puromycin-treated and non-
puromycin-treated P3 samples. Lane contents are as follows: lanes 1 and 7, 100 bp DNA ladder (Fermentas); lane 2, PCR products ampli-
fied from cDNA extracted from P3 fibroblasts treated with puromycin; lane 3, PCR products amplified from cDNA extracted from P3
fibroblasts cultured without puromycin; lane 4, PCR products amplified from cDNA extracted from control fibroblasts; lane 5, PCR prod-
ucts amplified from cDNA extracted from control lymphocytes; and lane 6, PCR reaction blank.
(D) Subcellular localization of C-terminal V5-tagged SAMC (p2-SAMC-V5) and the shortened SAMCD1–88 (p2-SAMCD-V5) in P2 fibro-
blasts stained with MitoTrackerOrange.
(E) Amounts of wild-type (WT) SAMC, p.Ala102Val SAMC, p.Val148Gly SAMC, p.Pro199Leu SAMC, SAMCD1–88, and endogenous
porin in mitochondria from SAM5D yeast transformed with WT SAMC-pYES2 (SAMC), p.Ala102Val SAMC-pYES2 (p.Ala102Val),
p.Val148Gly SAMC-pYES2 (p.Val148Gly), p.Pro199Leu SAMC-pYES2 (p.Pro199Leu), and short SAMC-pYES2 (SAMCD1–88). Equal
amounts of mitochondrial lysates (30 mg protein) were separated by SDS-PAGE, transferred to nitrocellulose, and immunodecorated
with the anti-hemagglutinin or the anti-porin antibody.
(F) Relative SLC25A26mRNA steady-state levels in fibroblasts as determined by qRT-PCR. Values are normalized to 18S rRNA levels. Error
bars show the SEM.
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Figure 2. In Vivo and In Vitro Pathology of the SLC25A26 Mutations
(A) 4-fold serial dilution of wild-type (WT) yeast cells, SAM5D cells, and SAM5D cells transformed with WT SAMC-pYES2 (SAMC),
p.Ala102Val SAMC-pYES2 (p.Ala102Val), p.Val148Gly SAMC-pYES2 (p.Val148Gly), p.Pro199Leu SAMC-pYES2 (p.Pro199Leu), and short
SAMC-pYES2 (SAMCD1–88) were plated on YP medium supplemented with 3% glycerol and 0.05% galactose for 72 hr at 30C.
(B and C) Liposomes reconstituted withWTor the indicated SAMC variants were preloaded with 10mM S-adenosylmethionine at 25C.
Transport was started with 1mM [3H]S-adenosylmethionine and terminated after (B) 45 s or (C) 60min. The values are means5 SD of at
least four independent experiments.ventilation and dichloroacetic acid treatment. The child
improved, and gross development was normal until 2 years
of age,when she experienced anadditional episode of severe
lactic acidosis (36 mmol/l) followed by cardiopulmonary
arrest and hypoxic brain damage. After this episode, the in-
dividual has remained severely handicapped. Activities of
respiratory-chain enzymes were normal in fibroblasts but
showeddecreasedactivities of complexes I, III, and IVinskel-
etalmuscle (Figure S1E).Muscle histologywas normal at day
6 but revealed both ragged red fibers and COX-negative
fiberswhen individual 2was 3 years of age (Figure S1F). Indi-
vidual 3 (P3, individual II:4 from family 3 in Figure 1A), born
to consanguineous parents of Moroccan decent, was deliv-
ered by caesarean section at 30 weeks 5 days after reduced
fetal movements, polyhydramnios, fetal hydrops, and poor
cardiotocography (CTG) readingswere noted from27weeks
of gestational age. She had normal antropometric parame-
ters (birthweight 1,300 g, length38 cm, andhead circumfer-
ence 27.5 cm) but presented with a poor Apgar score (3-5-6)
due tobradycardia,hypotonia, and respiratory insufficiency,
necessitating assisted ventilationwith high-frequency oscil-
lation. Urine lactate and pyruvate levels were 18 mmol/
mmol creatinine (reference: 1–285 mmol/mmol creatinine)
and 1.2 mmol/mmol creatinine (reference: 1–130 mmol/
mmol creatinine), respectively. Brain ultrasound demon-
strated cystic necrosis of the germinal matrix (extensive
symmetrical caudothalamic germinolysis) and mild striatal
arteriopathy. The child died of respiratory and multiple
organ failure at 5 days of age. Measurement of respiratory-
chain activity in fibroblasts demonstrated decreased com-
plex IV activity. Additional clinical descriptions and experi-
mental details are provided in the Supplemental Note.
Written informed consent was obtained from the par-
ents, and investigations were performed according to the
regional ethics committees at the Karolinska Institutet
(Sweden), the Saitama Medical University (Japan), and
Antwerp University Hospital (Belgium).The AmericanHomozygosity mapping, exome sequencing,5–11 and
Sanger confirmation (Figures 1A and 1B and Figure S2A)
revealed SLC25A26 mutations (GenBank: NM_173471.3)
in all affected individuals and their parents. We identi-
fied conserved missense mutations in P1, homozygous
for a c.443T>C (p.Val148Gly) substitution, and P2,
compound heterozygous for c.305C>T (p.Ala102Val) and
c.596C>T (p.Pro199Leu). P3 was homozygous for a splice
mutation (c.33þ1G>A) (Figure 1C), which results in
either a frameshift mutation in SLC25A26, when an alter-
native splice site in exon 2 is used, or a shorter polypeptide
lacking the first 88 amino acids (SAMCD1–88), as a result
of an alternative translation initiation site in exon 4
(Figure S2B). Cloning and sequencing of cDNA from P3
fibroblasts of this region confirmed the presence of
exclusively alternative splice variants (Figure S2C). The
shortened transcript lacks the first two transmembrane
helices (Figure S3) and failed to co-localize (Figure 1D) or
be detected in mitochondria by western blot analysis
(Figure 1E), indicating that it does not encode a functional
mitochondrial carrier protein. Additionally, the splice mu-
tation resulted in reduced SLC25A26 mRNA transcript
levels in fibroblasts from P3, whereas P1 and P2 samples
were unaffected (Figure 1F).
The conservation of all three missense mutations among
87 species (Ala102 [84%], Val148 [100%, including Leu
and Ile], and Pro199 [100%]) suggests that their replace-
ment might disrupt protein function. We also considered
the transversal scores of the altered SAMC residues (these
scores are a measure of the strength of the evolutionary
selection acting on the residues) from a study of the rate
of single-nucleotide evolution.12 These values (4.52 for
Ala102, 3.68 for Val148, and 5.15 for Pro199) are all
close to or greater than 3.7, previously shown to repre-
sent sites of functional importance in mitochondrial car-
riers.12 Furthermore, the position of all three SLC25A26
missense mutations in the structural homology modelJournal of Human Genetics 97, 761–768, November 5, 2015 763
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Figure 3. Affected Mitochondrial Translation
(A and B) Poisoned primer extension on total RNA from (A) fibroblasts or (B) skeletal-muscle mitochondria and subsequent size separa-
tion by denaturing PAGE. [32P] end-labeled oligo complement to the 30 terminus of 12S rRNA was annealed to RNA extracts and elon-
gated in the presence of dTTP and ddCTP byM-MLV reverse transcriptase. In the case of adenine dimethylation, reverse transcriptionwill
terminate upstream of the dimethylation, whereas in its absence, termination will occur immediately downstream of the first guanidine
residue because of ddCTP.
(C) Quantification of termination and read-through of (A) and (B).
(D) qRT-PCR of the steady-state levels of 12S and 16S rRNA in fibroblasts. Themean value of two independent experiments performed in
triplicate is shown.
(legend continued on next page)
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of SAMC also suggested a pathogenic effect of the muta-
tions (Figure S4).13 We confirmed pathogenicity by com-
plementation studies in an S. cerevisiae SAMC-null strain
(SAM5D)14 by revealing that the growth phenotype of
SAM5D cells on non-fermentable carbon sources could
not be restored by complementation of the knockout
strain with the p.Ala102Val, p.Pro199Leu, or SAMCD1–
88 variant. Only the p.Val148Gly altered SAMC partially
rescued the growth defect of SAM5D cells (Figure 2A).
Additionally, we measured SAM transport capacity in re-
constituted liposomes as previously described15–19 and
demonstrated a severe abrogation of SAM transport cap-
acity for all altered proteins (Figures 2B and 2C and
Figure S5). SAMCD1–88 was completely inactive, whereas
p.Ala102Val and p.Pro199Leu variants exhibited negli-
gible activity, and p.Val148Gly strongly inhibited SAMC
activity (15% of wild-type SAMC). All together, conserva-
tion scores, yeast complementation, and in vitro reconsti-
tution studies confirm the deleterious consequences of the
SLC25A26 mutations on SAMC function. Also supporting
this is that the various degrees of residual SAM-import
capacity correlated well with the severity of the clinical
presentation and biochemical phenotype in the affected
individuals.
Methylation is required for a multitude ofmitochondrial
processes, including RNA and protein modifications, and
we therefore investigated the status of adenine dimethyla-
tion in the hairpin loop at the 30 end of the mitochondrial
12S rRNA by poisoned primer extension,20 known to be
methylated viamtSAM.21–23 In control samples, themajor-
ity of 12S rRNA molecules were dimethylated at adenines
936–937, whereas fibroblasts from P3 (Figure 3A) and skel-
etal-muscle mitochondria from P1 (Figure 3B) revealed a
substantial shift from methylated to non-methylated ribo-
somal transcripts (Figure 3C). Surprisingly, not only did we
fail to observe a methylation defect in fibroblast samples
from individuals P1 and P2, but there was also substantial
termination of primer extension in P3 fibroblasts, suggest-
ing some methylation of 12S rRNA despite the complete
lack of SAMC activity. 12S rRNA steady-state levels are
dependent on adenine dimethylation,23 and in agreement
with this, 12S rRNA steady-state levels in fibroblasts from
P3 were decreased (Figure 3D), whereas all other transcripts
tested had only mild changes (Figures S6A and S6B).
Additionally, mitochondrial ribosomal assembly was only
moderately affected in P3, who showed reduced amounts
of the small and possible stabilization of the large
mitochondrial ribosome subunits (Figure 3E). Despite the(E) Ribosomal gradients (top panel) from fibroblast mitochondria of P
by centrifugation and then fractionated as previously described,24 w
the small ribosomal subunit (28S; MRPS18B) or large subunit (39S; M
some (55S) formation. Loading onto the gradient was controlled
(MRPS18B), mt-LSU (MRPL28), and tubulin. Additionally, a Coomas
(F) For determining de novo translation,25 fibroblasts were cultured f
protein extracts were separated by SDS-PAGE, and the gel was exposed
not shown.
(G) Western blot analysis of fibroblasts used antibodies against nucle
The Americanmild effect on mitochondrial ribosome assembly, de
novo mitochondrial translation25 was severely affected in
P3 fibroblasts (Figure 3F), possibly because methylation is
required for tRNA maturation. This defect is also reflected
by the reduced steady-state level of COXII (Figure 3G), a
subunit of complex IV, and most likely contributes to the
mitochondrial dysfunction in P1 skeletal muscle, which
showed reduced levels of complexes I and IV (Figure S1).
Several mitochondrial proteins are known to be methyl-
ated by S-adenosylmethionine-dependent methyltrans-
ferases.26,27 We studied the methylation status of three
known mitochondrial SAM targets, ADP/ATP translocators
ANT1 and ANT2, and the electron-transferring flavopro-
tein ETFB. Western blot analysis against di- and tri-methyl
lysine (DTML) revealed decreased methylation levels in all
fibroblast samples from affected individuals, and P3 was
the most severely affected (Figure 4A). Transfection of
cell lines from affected individuals with exogenous ANT1
and ANT2 further confirmed the methylation deficiency
(Figure 4B). Loss of protein methylation was further
rescued by wild-type SAMC in fibroblasts from P2 and P3
(Figure 4C).
Lipoic acid (LA) metabolism depends heavily on SAM-
dependent methylation within mitochondria.31 Individ-
ual P1 presented with high plasma glycine and low ATP
production in muscle when pyruvate was used as a sub-
strate, consistent with deficiencies of the glycine cleavage
system and the pyruvate dehydrogenase complex, both
of which require LA. These measurements were not
performed for individual P2 or P3. Fibroblasts from indi-
viduals P1–P3 showed reduced levels of the LA subunits py-
ruvate dehydrogenase complex E2 (PDHC-E2) and alpha-
ketoglutarate dehydrogenase E2 (a-KGDH-E2) (Figures 4D
and 4E), and P3 was the most severely affected. This
decrease was not secondary to the mitochondrial dysfunc-
tion observed, given that two independent samples from
individuals with unrelated mitochondrial diseases showed
normal levels of LA (M1 and M2 in Figure 4E), whereas
samples from individuals with mutations affecting LA
biosynthesis were severely reduced (B1–B4 in Figure 4E).
The final steps of coenzyme Q10 (CoQ10) biosynthesis,
including several methylation steps of the benzoquinone
ring, are performed within the mitochondrial network.32
We therefore measured CoQ10 levels in isolated skeletal-
muscle mitochondria from P1 as previously described7,28
and observed that they were severely decreased, pre-
sumably as a result of impaired CoQ10 biosynthesis
(Figure 4F). In order to investigate the bioenergetic1 and P3. Ribosomes were separated in 10%–30% sucrose gradient
ith slight modifications. Western blot analysis against subunits of
RPL28) revealed their individual migration and ribosomal mono-
by input western blot analysis (bottom panel) against mtSSU
sie stain is shown.
or 45 min in the presence of [35S] methionine and cysteine; then,
. The low-molecular-weight subunits of ND3, ATP8, and ND4L are
ar-encoded subunits of complexes I–V.
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Figure 4. Effects of Reduced Mitochondrial Methylation
(A) Steady-state levels of ANT1, ANT2, and ETFb (middle panels) in individuals P1–P3 and control cells (C1, C2, and C4), as well as DTML
levels (upper panel) normalized to HSP60.
(B) Control (C2) or P2 fibroblasts were transfected with V5-tagged isoforms of ANT (ANT1-V5 and ANT2-V5) for determining DTML
methylation of ANT1-V5 and ANT2-V5.
(C) Western blot analysis of DTML levels in samples from control (C2 and C3) and P2 and P3 fibroblasts transfected with empty vector
(mitoTurboRFP), wild-type SAMC (SAMC), V5-tagged SAMC (SAMC-V5), or the N-terminal-truncated SAMC (SAMCD-V5).
(D and E) Western blot analysis of the lipoic acid (LA) subunits pyruvate dehydrogenase complex E2 (PDHC-E2) and alpha-ketoglutarate
dehydrogenase E2 (a-KGDH-E2) in (D) control (C1 and C3) and P1 and P3 samples or in (E) control (C2) or affected (B1–B4, M1 andM2,
(legend continued on next page)
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consequences of reduced mtSAM import, we measured
both oxygen consumption (Figure 4G) and mitochondrial
ATP production rates (Figure 4H) in fibroblasts carrying
the mildest (P1) or null (P3) mutations. Fibroblasts from
P3 showed reduced oxygen consumption (Figure 4G) and
reduced mitochondrial ATP production rates (Figure 4H),
whereas P1 fibroblasts, in contrast to muscle samples
(Figure S1A), showed no defect. Finally, the biochemical
defects of P3 fibroblasts in the activity of complexes I
and IV was rescued by transiently expressing wild-
type and tagged wild-type SAMC, but not SAMCD1–88
(Figure 4I).
In summary, we have presented three individuals
affected by a primary defect in the mitochondrial methyl-
ome. Our results show that impaired SAM transport
into mitochondria causes a complex syndrome causing
multiple primary defects, including those affecting RNA
stability, protein modification, mitochondrial translation,
and the biosynthesis of CoQ10 and LA. We identified
three individuals who originate from different ethnic
groups and share striking similarities both biochemically
and clinically, consistent with the degree of residual
SAM-import capacity. Surprisingly, even though we stud-
ied SAMC-null samples, we detected some degree of
intra-mitochondrial methylation, suggesting that other
forms of methylation or recycling of methyl groups origi-
nating from imported methylated proteins might occur
within mitochondria.Supplemental Data
Supplemental Data include a Supplemental Note and six figures
and can be found with this article online at http://dx.doi.org/10.
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